Top Story

FDA accepts supplemental biologics license application for 12-week dosing of Eylea

December 11, 2017

The FDA has accepted a supplemental biologics license application from Regeneron for a 12-week dosing interval of Eylea for patients with wet age-related macular degeneration, the company announced in a press release.

Currently, the recommended dose of Eylea (aflibercept) for wet AMD is a 2-mg injection every 8 weeks after three initial monthly injections.

November approvals lead FDA activity in ophthalmology

December 10, 2017
The FDA’s ophthalmology-related news in November included device, drug and feasibility study approvals. Here are the four most-read FDA news stories published on…

Vyzulta approval tops November Glaucoma news

December 9, 2017
The most read glaucoma-related article on Healio.com/OSN last month was the FDA’s approval of Bausch + Lomb’s Vyzulta, a once-daily eye drop for lowering…
In the Journals

Cataract surgery can be ‘greener’

December 8, 2017
For each cataract surgery done at the Aravind Eye Care System in southern India, a fraction of the carbon footprint is produced with each phacoemulsification case…

Regeneron sees $388 million third quarter income

December 8, 2017
Regeneron posted a GAAP net income of $388 million, or $3.64 per share, for the third quarter of 2017, compared with a net income of $265 million, or $2.53 per share, in…
More Headlines »
Original Article

Impact of a Strabismus Surgery Suture Course for First- and Second-Year Ophthalmology Residents

Journal of Pediatric Ophthalmology and Strabismus, November/December 2017, Volume 54 Issue 6
To investigate the effectiveness of an eye muscle surgery course on first- and second-year postgraduate ophthalmology…
More »

Scratching Beneath the Surface to Manage Ocular Surface Disease

This activity is supported by an educational grant from Shire.

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the…
More »
Resource Centers
American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

Meeting News

VIDEO: IRIS Registry study shows diabetic macular edema undertreated in US

November 29, 2017
More »